Vandoeuvre Les Nancy

• TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Not authorised
  2024-511807-41-00 5 Hemophagocytic lymphohistiocytosis (HLH)
• Effect of Copper CU64 PSMA I&T scanning to detect potential disease spread to lymph nodes in men with newly diagnosed Prostate Cancer Not authorised
  2024-512754-16-00 5 Prostate cancer
• A clinical study of MK-7240 for the treatment of ulcerative colitis (MK-7240-001) Unknown
  2025-523766-25-00 5 Ulcerative colitis
• A study to investigate efficacy and safety with pegtibatinase compared to placebo in participants ≥12 to ≤65 years of age with classical hom … Pending
  2023-504135-40-00 5 Classical Homocystinuria
• CUSHMAH - Benefit of steroidogenesis inhibitors in Mild Cushing syndrome (Mild Autonomous Cortisol Secretion): a randomized trial in patient … Pending
  2023-507010-27-00 5 Primary Bilateral Macronodular Adrenal Hyperplasia causing moderate Cu
• Corticoid Therapy in Acute Myocarditis Pending
  2024-510602-90-00 5 Patients presenting with acute myocarditis proven by cardiac magnetic
• SEMAFORCRANIO : Multicenter, double-blind, parallel, randomized controlled trial of the efficacy of semaglutide in hypothalamic obesity seco … Pending
  2024-511114-20-00 5 Craniopharyngioma
• TIC-TAC-SAM « Comparison of two strategies of etoposide initiation in severe sporadic hemophagocytic lymphohistiocytosis in intensive care: … Pending
  2024-511807-41-01 5 Hemophagocytic lymphohistiocytosis (HLH)
• MInimal residual Disease Adapted Strategy / IFM 2020-02 Pending
  2024-513889-19-00 5 Multiple Myeloma
• Comparison of azathioprine to methotrexate in combination therapy with adalimumab in Crohn’s Disease: an open-label randomized controlled tr … Pending
  2024-514633-38-00 5 Crohn’s Disease
• FirST lines of biologics in pAtients with ulceRaTivE colitis: a Randomised controlled trial Pending
  2024-514964-24-00 5 ulcerative colitis
• LEAn Body Mass Normalization of OXaliplatin Based Chemotherapy Pending
  2024-515340-23-00 4 Colon cancer
• Apixaban/rivaroxaban Versus Aspirin for primary prevention of thrombo-embolic complications in JAK2V617F-positive myeloproliferative neoplas … Pending
  2024-515362-13-00 10 Philadelphia-negative myeloproliferative neoplasms are frequent and ch
• Randomized controlled trial evaluating the impact of mineralocorticoid receptor blockade by eplerenone on echocardiographic abnormalities am … Pending
  2024-515860-29-00 5 kidney transplantation
• Severe Erythema Multiforme - CORTICO Pending
  2024-516018-39-00 5 Erythema multiforme (EM) in its severe form managed at the hospital
• BEACON 2: A Multi-Arm, Multi-Stage Platform Trial For Relapsed Neuroblastoma Pending
  2024-516115-24-00 9 High risk relapsed neuroblastoma (relapsed or progressed after being d
• Defining Antibiotic Levels in Intensive care patients (DALI-2) protocol Pending
  2024-516232-10-00 6 Serious infections in critically ill patients treated with antibiotics
• Rituximab therapy in anti-MAG patients with characteristics of good responders: THERAMAG study Pending
  2024-516335-27-00 5 anti-MAG neuropathy
• A PRECISION MEDICINE RANDOMIZED TRIAL FOR PATIENTS WITH RELAPSED OR REFRACTORY T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA BASED ON A FUNCTIONAL APP … Pending
  2024-516570-30-00 4 Relapsed/refractory T-cell Acute Lymphoblastic Leukemia
• Efficacy, safety, and tolerability study of lunsekimig compared with placebo in adult participants with inadequately controlled chronic obst … Pending
  2024-518016-39-00 10 Respiratory tract diseases
• SPironolactONe for the maintenance of Sinus Rhythm in hypertensive patients with atrial fibrillation and preserved left ventricular ejection … Pending
  2024-518146-25-00 5 patients with atrial fibrillation and preserved left ventricular eject
• OCEAN(a)-PreEvent - Olpasiran trials of Cardiovascular Events And LipoproteiN(a) reduction to Prevent first major cardiovascular Events Pending
  2025-520554-11-00 5 Cardiovascular Disease
• A maintenance study to investigate the efficacy and safety of duvakitug in participants with moderately to severely active Crohn’s disease Pending
  2025-521037-86-00 5 Immune system diseases
• A Phase 2, single arm Multicenter, Study testing Mezigdomide, Carfilzomib, and Dexamethasone (480Kd) in Participants with Relapsed or Refrac … Pending
  2025-521090-14-00 4 Patients with relapsed/refractory symptomatic multiple myeloma (MM)

Showing 1–24 of 285 trials